天然产物研究与开发 ›› 2016, Vol. 28 ›› Issue (Suppl1): 97-100.doi: 10.16333/j.10016880.2016.S.024

• 开发研究 • 上一篇    下一篇

表达NDK105蛋白rCHO细胞在批次培养与浓缩物流加培养中的生长与代谢特性

王美玲,任东升*,段鑫,张艳   

  1. 西藏诺迪康药业股份有限公司,成都 610003
  • 出版日期:2016-06-30 发布日期:2017-03-02

Growth and Metabolism of NDK105 Producing rCHO Cells in Batch and Concentrate FedBatch Culture

WANG Meiling,REN Dongsheng*,DUAN Xin,ZHAGNG Yan   

  1. Tibet Rhiola Pharmaceutical Holding Co,Chengdu 610003,China
  • Online:2016-06-30 Published:2017-03-02

摘要: 人程序性死亡受体抗体在抗肿瘤,抗感染,抗自身免疫性疾病等方面有广阔的市场产景。本实验以表达PD1抗体的rCHO细胞为研究对象,考察了在培养过程中浓缩物流加培养对 rCHO 细胞生长、葡萄糖消耗,以及副产物乳酸、氨生成的影响。结果表明:浓缩物流加培养过程中,活细胞密度达到 3.1×106 Cells/mL,较批次培养提高1.6倍,细胞培养时间延长;而乳酸生成大幅减少,NDK105产量增加。本研究所采用的研究方法和控制策略为优化CHO细胞培养过程 和NDK105成功产业化奠定了基础。

关键词: CHO细胞, NDK105蛋白, 乳酸

Abstract: NDK105 is antibody of programmed death 1 receptor that has great potential in antitumor,antiinfection and autoimmune disease.We studied the effects of concentrate fedbatch culturing on rCHO growth,glucose consumption,as well as lactate and ammonia production.It is found that the maximum viable cell density in concentrate fedbatch culture reaches 3.1×106Cells/mL,which is 1.6fold in batch culture.At the same time,the culture time of rCHO were extended,and also,compared with the batch process,the newly developed concentrate fedbatch process reduced lactate production and improved NDK105 production.This concentrate fedbatch process would therefore facilitate the productions of therapeutic antibody by rCHO cells.

Key words: CHO cells, NDK105, lactate

中图分类号: 

R392